全国范围内与唐氏综合症胎儿减少相关的变量。

IF 1.7 4区 生物学 Q3 GENETICS & HEREDITY
Petrus H F M van Casteren, Gert de Graaf, Frank Buckley, Brian G Skotko
{"title":"全国范围内与唐氏综合症胎儿减少相关的变量。","authors":"Petrus H F M van Casteren, Gert de Graaf, Frank Buckley, Brian G Skotko","doi":"10.1002/ajmg.a.64228","DOIUrl":null,"url":null,"abstract":"<p><p>In this study, we sought to analyze the associations of global macroeconomic policy decisions on live births with Down syndrome (DS). As countries made prenatal screening more available and financially covered by their governments, we modeled the impact on the \"reduction percentage\" for DS-that is, the percentage of fetuses with DS that were not born as a consequence of selective terminations. The log-odds of the reduction in live births of children with DS (due to selective abortion) were estimated using maternal age-based prevalence models and actual birth data. These log-odds were then predicted using independent variables, including the availability and reimbursement of prenatal screening, maternal age, Gross National Income per capita, and country-specific effects. Data were analyzed using least squares regression with robust standard errors and model validation. When there is a full change from \"no availability of screening\" to \"serum screening available and reimbursed,\" we observed a large effect on the reduction percentage (OR = 3.24, p = 0.0001). If a country, whose baseline reduction percentage was 5%, 25%, or 50%, were to make this policy switch, then the reduction would be expected to increase to about 15%, 52%, and 76%, respectively, when all other variables are held constant. Increases in maternal age and Gross National Income also were associated with increased reduction percentages. If a country were to expand the availability or reimbursement of prenatal screening for DS, while all other factors are constant, that country should also expect to have fewer live births with DS as a consequence.</p>","PeriodicalId":7507,"journal":{"name":"American Journal of Medical Genetics Part A","volume":" ","pages":"e64228"},"PeriodicalIF":1.7000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome.\",\"authors\":\"Petrus H F M van Casteren, Gert de Graaf, Frank Buckley, Brian G Skotko\",\"doi\":\"10.1002/ajmg.a.64228\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this study, we sought to analyze the associations of global macroeconomic policy decisions on live births with Down syndrome (DS). As countries made prenatal screening more available and financially covered by their governments, we modeled the impact on the \\\"reduction percentage\\\" for DS-that is, the percentage of fetuses with DS that were not born as a consequence of selective terminations. The log-odds of the reduction in live births of children with DS (due to selective abortion) were estimated using maternal age-based prevalence models and actual birth data. These log-odds were then predicted using independent variables, including the availability and reimbursement of prenatal screening, maternal age, Gross National Income per capita, and country-specific effects. Data were analyzed using least squares regression with robust standard errors and model validation. When there is a full change from \\\"no availability of screening\\\" to \\\"serum screening available and reimbursed,\\\" we observed a large effect on the reduction percentage (OR = 3.24, p = 0.0001). If a country, whose baseline reduction percentage was 5%, 25%, or 50%, were to make this policy switch, then the reduction would be expected to increase to about 15%, 52%, and 76%, respectively, when all other variables are held constant. Increases in maternal age and Gross National Income also were associated with increased reduction percentages. If a country were to expand the availability or reimbursement of prenatal screening for DS, while all other factors are constant, that country should also expect to have fewer live births with DS as a consequence.</p>\",\"PeriodicalId\":7507,\"journal\":{\"name\":\"American Journal of Medical Genetics Part A\",\"volume\":\" \",\"pages\":\"e64228\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Medical Genetics Part A\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1002/ajmg.a.64228\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medical Genetics Part A","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/ajmg.a.64228","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

在这项研究中,我们试图分析全球宏观经济政策决定与唐氏综合症(DS)活产的关系。随着各国提供更多的产前筛查,并由政府提供财政支持,我们模拟了对DS“减少百分比”的影响,即由于选择性终止妊娠而未出生的DS胎儿的百分比。使用基于年龄的产妇患病率模型和实际出生数据估计了退行性妊娠儿童(由于选择性流产)活产减少的对数赔率。然后使用独立变量预测这些对数赔率,包括产前筛查的可用性和报销,产妇年龄,人均国民总收入和国家具体影响。数据分析采用最小二乘回归稳健标准误差和模型验证。当从“无筛查可用性”完全改变为“可进行血清筛查并可报销”时,我们观察到对减少百分比的巨大影响(OR = 3.24, p = 0.0001)。如果一个基准减排百分比为5%、25%或50%的国家进行这一政策转换,那么在所有其他变量保持不变的情况下,预计减排将分别增加到约15%、52%和76%。产妇年龄的增加和国民总收入的增加也与减少百分比的增加有关。如果一个国家在所有其他因素不变的情况下扩大提供或报销唐氏症产前筛查,那么该国也应该预期唐氏症的活产会减少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Countrywide Variables Associated With the Reduction of Fetuses With Down Syndrome.

In this study, we sought to analyze the associations of global macroeconomic policy decisions on live births with Down syndrome (DS). As countries made prenatal screening more available and financially covered by their governments, we modeled the impact on the "reduction percentage" for DS-that is, the percentage of fetuses with DS that were not born as a consequence of selective terminations. The log-odds of the reduction in live births of children with DS (due to selective abortion) were estimated using maternal age-based prevalence models and actual birth data. These log-odds were then predicted using independent variables, including the availability and reimbursement of prenatal screening, maternal age, Gross National Income per capita, and country-specific effects. Data were analyzed using least squares regression with robust standard errors and model validation. When there is a full change from "no availability of screening" to "serum screening available and reimbursed," we observed a large effect on the reduction percentage (OR = 3.24, p = 0.0001). If a country, whose baseline reduction percentage was 5%, 25%, or 50%, were to make this policy switch, then the reduction would be expected to increase to about 15%, 52%, and 76%, respectively, when all other variables are held constant. Increases in maternal age and Gross National Income also were associated with increased reduction percentages. If a country were to expand the availability or reimbursement of prenatal screening for DS, while all other factors are constant, that country should also expect to have fewer live births with DS as a consequence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.50
自引率
5.00%
发文量
432
审稿时长
2-4 weeks
期刊介绍: The American Journal of Medical Genetics - Part A (AJMG) gives you continuous coverage of all biological and medical aspects of genetic disorders and birth defects, as well as in-depth documentation of phenotype analysis within the current context of genotype/phenotype correlations. In addition to Part A , AJMG also publishes two other parts: Part B: Neuropsychiatric Genetics , covering experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders. Part C: Seminars in Medical Genetics , guest-edited collections of thematic reviews of topical interest to the readership of AJMG .
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信